99mTc-DARPinG3 SPECT/CT for Non-invasive HER2-AX in Breast Cancer With Metastatic Lymph Nodes Before Targeted Therapy
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL
Conditions: Breast Cancer Female
Interventions: DRUG: 99mTc-DARPinG3 SPECT/CT
Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences
Collaborators: Uppsala University